Osteopontin regulation in cultured rat renal epithelial cells

Kidney International

Volumn 51, Issue 6, 1997, Pages 1766-1773

  Malyankar, Uriel M ^a   Almeida, Manuela ^a   Johnson, Richard J ^a   Pichler, Raimund H ^a   Giachelli, Cecilia M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; OSTEOPONTIN; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; INTERSTITIAL NEPHRITIS; KIDNEY CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030965979     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.243     Document Type: Article

References (55)

1. KUNCIO GS, NEILSON EG, HAVERTY T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550-556, 1991
2. DIAMOND JR, KEES FOLTS D, DING G, FRYE JE, RESTREPO NC: Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 266:F926-F933, 1994
3. SCHREINER GF, HARRIS KPG, PURKERSON ML, KLAHR S: Immunological aspects of acute ureteral obstruction. Kidney Int 34:487-493, 1988
4. HARRIS KPG, SCHREINER GF, PURKERSON ML, KLAHR S: Effect of leukocyte depletion on the post-obstructed rat kidney. Kidney Int 36:210-215, 1989
5. KLAHR S: New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 18:689-699, 1991
6. BOHLE A, MACKENSEN-HAEN S, VON GISE H: Significance of tubulo-interstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: A morphometric contribution. Am J Nephrol 7:421-433, 1987
7. STRIKER GE, SCHAINUCK LE, CUTLER RE, BENDITT EP: Structural-functional correlations in renal disease. 1. The correlations. Hum Pathol 1:615-630, 1987
8. GIACHELLI CM, SCHWARTZ SM, LIAW L: Molecular and cellular biology of osteopontin: Potential role in cardiovascular disease. Trend Cardiovasc Med 5:88-95, 1995
9. GIACHELLI CM, PICHLER R, LOMBARDI D, DENHARDT DT, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524, 1994
10. SHIRAGA H, MIN W, VAN DUSEN WJ, CLAYMAN MD, MINER D, TERRELL CH, SHERBOTIE JR, FOREMAN JW, PRZYSIECKI C, NEILSON EG, HOYER JR: Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426-430, 1992
11. PICHLER R, GIACHELLI CM, LOMBARDI D, PIPPIN J, GORDON K, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Tubulointerstitial disease in glomerulonephritis: Potential role of osteopontin (uropontin). Am J Pathol 144:915-926, 1994
12. PICHLER RHT, FRANCESCHINI N, YOUNG, BA, HUGO C, ANDOH T, BURDMANN E, SHANKLAND SJ, GIACHELLI CM, ALPERS CE, BENNETT WM, COUSER WG, JOHNSON RJ: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
13. EDDY AA, GIACHELLI CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546-1557, 1995
14. DIAMOND JR, KEES-FOLTS D, RICARDO SD, PRUZNAK A, EUFEMIO M: Early and persistent up-regulation of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 146:1455-1466, 1995
15. SINGH RP, PATARCA R, SCHWARTZ J, SINGH P, CANTOR H: Definition of a specific interaction between early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 171:1931-1942, 1990
16. LOMBARDI DM, MOMBERG AA, JOHNSON R, PICHLER R, MURRY CE, GIACHELLI CM: Neutralizing antibodies directed against osteopontin inhibit f-met-leu-phe (FMLP)-induced macrophage infiltration in rat skin. FASEB J 10:A1293, 1996
17. NASU K, IHIDA T, SETOGUCHI M, HIGUCHI Y, AKIZUKI S, YAMAMOTO S: Expression of wild-type and mutated rabbit osteopontin in Escherichia coli and their effects on adhesion and migration of P388D1 cells. Biochem J 307:257-265, 1995
18. PADANILAM BJ, MARTIN DR, HAMMERMAN MR: Insulin-like growth factor I-enhanced renal expression of osteopontin following acute ischemic injury in rat. Endocrinol 137:2133-2140, 1996
19. MILLER SB, MARTIN DR, KISSANE J. HAMMERMAN MR: Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 89:11876-11880, 1992
20. LE QC, DAVIS CL, GIACHELLI CM, JOHNSON RJ, HUDKINS KL, ALPERS CE: Osteopontin expression in renal transplant biopsies, (abstract) Lab Invest 70:158A, 1994
21. HWANG S, LOPEZ CA, HECK DE, GARDNER CR, LASKIN DL, LASKIN JD, DENHARDT DT: Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 269:711-715, 1994
22. PICHLER R, GIACHELLI C, YOUNG B, ALPERS CE, COUSER WG, JOHNSON RJ: The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: The glomerular cytokine theory. Miner Electrol Metab 21:317-327, 1995
23. DE LARCO JE, TODARO GJ: Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation. J Cell Physiol 94:335-342, 1978
24. SUZUKI E, HIRATA Y, HAYAKAWA H, OMATA M, KOJIMA M, KANGAWA K, MINAMINO N, MATSUO H: Evidence for C-type natriuretic peptide production in the rat kidney. Biochem Biophys Res Commun 192:532-538, 1993
25. WALKER C, EVERITT J, FREED JJ, KNUDSON AG, WHITELY LO: Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma. Cancer Res 51:2973-2978, 1991
26. FRANCH HA, SHAY JW, ALPERN RJ, PREISIG PA: Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy. J Cell Biol 129:245-254, 1995
27. GIACHELLI CM, BAE N, LOMBARDI D, MAJESKY M, SCHWARTZ SM: Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun 177:867-873, 1991
28. MURRY CE, GIACHELLI CM, SCHWARTZ SM, VRACKO R: Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145:1450-1462, 1994
29. GIACHELLI CM, BAE N, ALMEIDA M, DENHARDT DT, ALPERS CE, SCHWARTZ SM: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92:1686-1696, 1993
30. LIAW L, ALMEIDA M, HART CE, SCHWARTZ SM, GIACHELLI CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 74:214-224, 1994
31. GIACHELLI CM, MAJESKY MW, SCHWARTZ SM: Developmentally regulated cytochrome P4501A1 expression in cultured rat vascular smooth muscle cells. J Biol Chem 266:3981-3986, 1991
32. AUSUBEL FM, BRENT R, KINGSTON RE, MOORE DD, SEIDMAN JG, SMITH JA, STRUHL K: Current Protocols in Molecular Biology. John Wiley and Sons, Inc. 1994, pp 4.10.1-4.10.3
33. DEGEN JL, NEUBAUER MG, FRIEZNER SJ, SEYFRIED CE, MORRIS DR: Regulation of protein synthesis in mitogen-activated bovine lymphocytes. J Biol Chem 258:12153-12162, 1983
34. UMEKAWA T, YAMATE T, AMASAKI N, KOHRI K, KURITA T: Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Ural Int a55:6-10, 1995
35. SHANKLAND SJ, PIPPIN J, PICHLER RH, GORDON KL, FRIEDMAN S, GOLD LI, JOHNSON RJ, COUSER WG: Differential expression of transforming growth factor beta isoforms and receptors in experimental membranous nephropathy. Kidney Int 50:116-124, 1996
36. DING G, PESEK-DIAMOND I, DIAMOND JR: Cholesterol, macrophages, and gene expression of TGF-B and fibronectin during nephrosis. Am J Physiol 264:F577-584, 1993
37. COIMBRA T, WIGGINS R, NOH JW, MERRITT S, PHAN SH: Transforming growth factor beta production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 138:223-243, 1991
38. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
39. SHANKLAND SJ, SCHOLEY JW: Expression of transforming growth factor B1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
40. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor B1. Nature 346-374:1990
41. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y, PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming growth factor beta protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
42. SHARMA K, YULIN J, GUO J, ZIYADEH: Neutralization of TGF-B by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in streptozotocin-diabetic mice. Diabetes 45:522-530, 1996
43. VERSTREPEN WA, NOUWEN EJ, ZHU MQ, GHIELLI M, DEBROE ME: Time course of growth factor expression in mercuric chloride acute renal failure. Nephrol Dial Transplant 10:1361-1371, 1995
44. TAIRA T, YOSHIMURA A, IIZUKA K, INUI K, OSHIDEN K, IWASAKI S, IDEURA T, KOSHIKAWA S: Expression of epidermal growth factor and its receptor in rabbits with ischaemic acute renal failure. Virchows Arch 427:583-588, 1996
45. COWLEY BD, GUDAPATY S: Temporal alterations in regional gene expression after nephrotoxic renal injury. J Lab Clin Med 125:187-199, 1995
46. HUMES HD, CIESLINSKI DA, COIMBRA TM, MESSANA JM, GALVAO C: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in post-ischemic acute renal failure. J Clin Invest 84:1757-1761, 1989
47. COIMBRA TM, CIESLINSKI DA, HUMES HD: Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 259:F438-F443, 1990
48. KUBOTA T, ZHANG Q, WRANA JL, BER R, AUBIN JE, BUTLER WT, SODEK J: Multiple forms of sppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: Regulation by TGFβ. Biochem Biophys Res Commun 162:1453-1459, 1989
49. RODAN SB, WESOLOWSKI G, YOON K, RODAN GA: Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. J Biol Chem 264:19934-19941, 1989
50. GREEN RS, LIEB ME, WEINTRAUB AS, GACHERU SN, ROSENFIELD CL, SHAH S, KAGAN HM, TAUBMAN MB: Identification of lysyl oxidase and other platelet-derived growth factor-inducible genes in vascular smooth muscle cells by differential screening. Lab Invest 73:476-482, 1995
51. NODA M, VOGEL RL, HASSON DM, RODAN GA: Leukemia Inhibitory factor suppresses proliferation, alkaline phosphatase activity, and type I collagen messenger RNA level and enhances osteopontin mRNA level in murine osteoblast-like (MC3T3E1) cells. Endocrinol 127:185-190, 1990
52. JIN CH, MIYAURA C, ISHIMI Y, HONG MH, SATO T, ABE E, SUDA T: Interleukin 1 regulated the expression of osteopontin mRNA by osteoblasts. Mol Cell Endocrinol 74:221-228, 1990
53. NODA M, RODAN GA: Type beta transforming growth factor regulates expression of genes encoding bone matrix proteins. Connective Tis Res 21:71-75, 1989
54. DUBOIS CM, RUSCETTI RW, STANKOVA J, KELLER JR: Transforming growth factor-beta regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 83:3138-3145, 1994
55. FINDER J, STARK WW, NAKAYAMA DK, GELLER D, WASSERLOOS K, PITT BR, DAVIES P: TGF-beta regulates production of NO in pulmonary artery smooth msucle cells by inhibiting expression of NOS. Am J Physiol 268:862-867, 1995